Business Standard

Vaccine will protect against new variant: Principal Scientific Advisor

Govt will initiate studies to see relationship between new strain and seriousness of the disease; there have been 17 changes in spike protein of the virus, of which eight are key

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Raghavan said that the increased transmissibility of the UK variant is a cause of concern.

Ruchika Chitravanshi New Delhi
Existing vaccines for Covid-19 will protect against the new variants, the government said on Tuesday, as there is no evidence to prove otherwise.

The changes in the variants, reported in the UK and South Africa, were not sufficient to make the vaccines ineffective, Principal Scientific Advisor K Vijay Raghavan told reporters.

India has set up the Indian SARS-CoV-2 Genomics Consortium of ten government labs which would test and sequence samples from international travellers as well samples of those being admitted to hospitals. The government will initiate studies to see the relationship between the new variant and the seriousness of the disease.

Raghavan termed

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in